Approbation and validation of Russian version of the interstitial cystitis symptoms and problem index

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Improving the effectiveness of diagnosing and treating patients with primary bladder pain syndrome is crucial in current urology owing to the high prevalence of the condition, its significant impact on the quality of life, and the similarity of its clinical manifestations to other diseases. The clinical manifestations of primary bladder pain syndrome is typically evaluated using specialized questionnaires, with one of the most commonly utilized being the Interstitial Cystitis Symptoms and Problem Index.

AIM: This study aimed to validate the Russian version of the Interstitial Cystitis Symptoms and Problem Index and thus assess its reliability and validity in accurately measuring the symptoms and problems associated with interstitial cystitis.

MATERIALS AND METHODS: The study included 62 participants and divided them into two groups. Group A included 32 patients diagnosed with primary bladder pain syndrome, comprising 26 women and 6 men, with an average age of 55 years. Group B consisted of 30 conditionally healthy volunteers, comprising 20 men and 10 women, with an average age of 46 years. All participants were required to complete the Russian version of the Interstitial Cystitis Symptoms and Problem Index, Pelvic Pain and Urgency/Frequency (PUF) scale, and International Prostate Symptom Score (IPSS) and maintain a voiding diary. Additionally, patients with PBPS underwent cystoscopy with bladder hydrodistention. Data collected from the participants were utilized to determine the internal consistency, external validity, and test–retest reliability of the questionnaires using the interclass correlation coefficient.

RESULTS: The mean of the Interstitial Cystitis Symptoms and Problem Index total in group A was 31.55 ± 7.07, which significantly (p < 0.001) exceeded the score of group B (2.90 ± 1.47). The Cronbach’s alpha of the total and “ICSI” and “ICPI” domains was 0.990, 0.834, and 0.854 respectively, confirming the high internal consistency of the Russian version of the Interstitial Cystitis Symptoms and Problem Index. External validity was verified by the relevant correlations with other questionnaires. Moreover, the total score of the questionnaire correlated with the clinical manifestations of primary bladder pain syndrome, the presence of Hunner’s lesions, and bladder capacity.

CONCLUSIONS: The study findings indicate that the Russian version of the Interstitial Cystitis Symptoms and Problem Index exhibits good validity and reliability. Therefore, it can be recommended for use in clinical practice as an effective tool for assessing symptoms and problems associated with interstitial cystitis.

About the authors

Natalia A. Bekker

Ural State Medical University

Author for correspondence.
Email: bekker97@inbox.ru
ORCID iD: 0009-0008-2148-9366
SPIN-code: 3377-1997

MD

Russian Federation, Ekaterinburg

Ekaterina S. Filippova

Ural State Medical University; Sverdlovsk Regional Clinical Hospital No. 1

Email: filippova.cat@yandex.ru
ORCID iD: 0000-0003-3065-3953
SPIN-code: 6364-8190

MD, Dr. Sci. (Medicine)

Russian Federation, Ekaterinburg; Ekaterinburg

Aleksandr V. Zyrianov

Ural State Medical University; Sverdlovsk Regional Clinical Hospital No. 1

Email: zav1965@mail.ru
ORCID iD: 0000-0001-8105-7233
SPIN-code: 6193-4204

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Ekaterinburg; Ekaterinburg

Igor V. Bazhenov

Ural State Medical University; Sverdlovsk Regional Clinical Hospital No. 1

Email: ivbazhenov@mis66.ru
ORCID iD: 0000-0003-1745-700X
SPIN-code: 7269-7282

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Ekaterinburg; Ekaterinburg

Albert A. Makaryan

Ural State Medical University

Email: walter2711@mail.ru
SPIN-code: 7799-9585

MD, Cand. Sci. (Medicine)

Russian Federation, Ekaterinburg

References

  1. Engeler D, Baranowski AP, Berghmans B, et al. Chronic pelvic pain. EAU Guidelines, 2024. Available from: https://uroweb.org/guidelines/chronic-pelvic-pain
  2. Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014;175:30–37. doi: 10.1016/j. ejogrb.2013.12.041
  3. Mirkin YaB, Karapetyan AV. Interstitial cystitis: pathogenesis, diagnostics and treatment (part 2). Experimental and Clinical Urology. 2018;(2):118–123. EDN: RWHBXX
  4. Kuzmin IV, Ignashov YuA, Slesarevskaya MN, Al-Shukri SH. Bladder pain syndrome in women: performance criteria and prognosis of treatment outcomes. Experimental and Clinical Urology. 2020;(2): 142–148. EDN: NFVUFY doi: 10.29188/2222-8543-2020-12-2-142-148
  5. Slesarevskaya MN, Kuzmin IV, Ignashov YuA. Characteristics of symptoms and psychosomatic status in women with chronic pelvic pain syndrome. Urology reports (St. Petersburg). 2015;5(3):16–19. EDN: VHUCAT doi: 10.17816/uroved5316-19
  6. Slesarevskaya MN, Ignashov YuA, Kuzmin IV. Current approaches to the diagnostic of bladder pain syndrome. Urology reports (St. Petersburg). 2017;7(2):25–30. EDN: YUCBMP doi: 10.17816/uroved7225-30
  7. Zaitsev AV, Sharov MN, Ibragimov RA, et al. Painful bladder syndrome/interstitial cystitis: modern approaches to diagnosis and treatment. Ambulance Doctor. 2018;(8):16–26. EDN: YLJJWX
  8. Al-Shukri SK, Kuzmin IV, Slesarevskaya MN, Ignashov YuA. Use of the Russian version of pelvic pain and urgency/frequency patient symptom scale (PUF scale) in patients with the bladder pain syndrome. Urology reports (St. Petersburg). 2017;7(2):5–9. EDN: YUCBMP doi: 10.17816/uroved725-9
  9. O’Leary MP, Sant GR, Fowler FJ Jr, et al. The interstitial cystitis symptom index and problem index. Urology. 1997;49(5S1):58–63. doi: 10.1016/s0090-4295(99)80333-1
  10. Lubeck DP, Whitmore K, Sant GR, et al. Psychometric validation of the O’leary-Sant Interstitial Cystitis Symptom Index in a clinical trial of pentosan polysulfate sodium. Urology. 2001;57(6S1):62–66. doi: 10.1016/s0090-4295(01)01126-8
  11. Esen B, Obaid K, Süer E, et al. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index. Neurourol Urodyn. 2020;39(8):2338–2343. doi: 10.1002/nau.24492
  12. Huang M-C, Hsieh C-H, Chang W-C, et al. Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O’Leary-Sant Interstitial Cystitis Symptom and Problem Indexes. Taiwan J Obstet Gynecol. 2018;57(5):718–721. doi: 10.1016/j.tjog.2018.08.019
  13. Victal ML, D’Ancona CAL, Junqueira RG, et al. Test-retest reliability and discriminant validity for the Brazilian version of “The interstitial cystitis symptom index and problem index” and “Pelvic pain and urgency/frequency (PUF) patient symptom scale” instruments. Transl Androl Urol. 2015;4(6):594–599. doi: 10.3978/j.issn.2223-4683.2015.11.01

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ №ФС77-65570 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies